SCHEMBL3215675

SCHEMBL3215675

CCOC(=O)Cc1ccc(N(Cc2cnccn2)c2ccc(OC(F)F)c(OC(F)F)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.38
SYK P43405 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
TBXAS1 P24557 1/20 0.35
MAOB P27338 1/20 0.35
DHFR P00374 2/20 0.34
FGFR1 P11362 1/20 0.33
FGFR2 P21802 1/20 0.33
FGFR4 P22455 1/20 0.33
FGFR3 P22607 1/20 0.33
KDR P35968 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
HDAC1 Q13547 1/20 0.33
FNTA P49354 1/20 0.33
FNTB P49356 1/20 0.33
CYP4Z1 Q86W10 1/20 0.33
KMT2A Q03164 1/20 0.33
NLRP3 Q96P20 1/20 0.33
ALDH1A1 P00352 1/20 0.32
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3130997 0.88 PDE4A (0.42) GAATDP1FGFR1FGFR2FGFR4
SCHEMBL3122279 0.86 ALDH1A1 (0.43) GAASYKDHFRKMT2AALDH1A1
SCHEMBL3199280 0.85 PDE4B (0.36) GAASYKTBXAS1MAOBDHFR
SCHEMBL3131421 0.84 SYK (0.45) GAASYKFGFR1FGFR2FGFR4
SCHEMBL3210508 0.82 TRPM8 (0.37) SYKTBXAS1MAOBDHFRCYP4Z1
SCHEMBL3132242 0.82 FGFR1 (0.35) GAATDP1FGFR1FGFR2FGFR4
SCHEMBL3120621 0.82 PDE4A (0.40) GAASYKHDAC1
SCHEMBL3128010 0.81 RXRA (0.43) KMT2ARAB9A
SCHEMBL3129693 0.80 GRM2 (0.44) KMT2AALDH1A1
SCHEMBL3203252 0.80 HRH4 (0.40) SYKTBXAS1MAOBDHFRCYP4Z1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B GAA 736/4885SYK 2747/4885TDP1 70/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.